FacebookX(旧Twitter)Instagram

業績一覧(論文業績)

論文業績

英文総説・著書

  1. K Tominaga, T Tanaka, M Kanazawa, S Watanabe, R Nemoto, K Abe, A Kanamori, A Yamamiya, K Goda, Y Kushima, K Chibana, T Masawa, T Fukuda, T Hibi and A Irisawa. A Case of Crohn’s Disease with Cardiac Tamponade Caused by Tuberculous Pericarditis: Assessment of a Rare Phenomenon. Healthcare Jun 9;9(6):695. 2021
  2. Toyonaga T, Kobayashi T, Kuronuma S, Ueno A, Kiyohara H, Okabayashi S, Takeuchi O, Redfern CPF, Terai H, Ozaki R, Sagami S, Nakano M, Coulthard SA, Tanaka Y, Hibi T. Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation. J Gastroenterol Sep 4. doi: 10.1007/s00535-021-01820-0. Online ahead of print. 2021
  3. Sagami S, Kobayashi T, Aihara K, Umeda M, Morikubo H, Matsubayashi M, Kiyohara H, Nakano M, Ohbu M, Hibi T. Transperineal Ultrasound Predicts Endoscopic and Histological Healing in Ulcerative Colitis. Aliment Pharmacol Ther Jun;51(12):1373-1383. 2020
  4. Okabayashi S, Kobayashi T, Hibi T. Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns?- J Anus Rectum Colon. Jan 30;4(1):1-13. 2020
  5. Ben-Horin S, Zhao Y, Guo J, Mao R, Novack L, Sergienko R, Zhang J, Kobayashi T, Hibi T, Chowers Y, Colombel JF, Peyrin-Biroulet L, Kaplan G, Chen MH. Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials. BMJ Open. 9(1):e024222. 2019
  6. Yagisawa K, Kobayashi T, Ozaki R, Okabayashi S, Toyonaga T, Miura M, Hayashida M, Saito E, Nakano M, Matsubara H, Hisamatsu T, Hibi T. Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients. Intest Res. 17(1):87-93. 2019
  7. Kobayashi T, Hisamatsu T, Suzuki Y, Ogata H, Andoh A, Araki T, Hokari R, Iijima H, Ikeuchi H, Ishiguro Y, Kato S, Kunisaki R, Matsumoto T, Motoya S, Nagahori M, Nakamura S, Nakase H, Tsujikawa T, Sasaki M, Yokoyama K, Yoshimura N, Watanabe K, Katafuchi M, Watanabe M, Hibi T. Predicting outcomes to optimize disease management in inflammatory bowel diseases in Japan:their differences and similarities to Western countries. Intestinal Research. 16(2):168-177. 2018
  8. Hibi T, Hisamatsu T, Kobayashi T. Advances in Endoscopy in Inflammatory Bowel Disease. Springer Japan 2017
  9. Hibi T. A new start for 'Intestinal Research' as an official journal of AOCC.Intest Res Jan;14(1):1 2016
  10. Kobayashi T and Hibi T. Ulcerative colitis: Which makes patients happier, surgery or anti-TNF? Nat Rev Gastroenterol Hepatol May 2014 in press.
  11. Hosoe N, Ogata H, Hibi T. Endoscopic imaging of parasites in the human digestive tract. Parasitol Int 63(1):216-20 Feb 2014
  12. Matsuoka K, Hibi T. Treatment guidelines in inflammatory bowel disease: the Japanese perspectives. Dig Dis 31(3-4):363-7 Nov 2013
  13. Naganuma M, Sakuraba A, Hibi T. Ulcerative colitis; prevention of relapse. Expert Rev Gastroenterol Hepatol 7(4):341-51 May 2013
サイトマップサイトマップページトップページトップ